A Spontaneously Ruptured Gastric Stromal Tumor with Cystic Degeneration Presenting as Hemoperitoneum: A Case Report

Journal of Korean Medical Science

Volumn 18, Issue 5, 2003, Pages 751-755

  Cheon, Young Koog ^a   Jung, In Seop ^a   Cho, Young Deok ^a   Kim, Jin Oh ^a   Lee, Joon Seong ^a   Lee, Moon Sung ^a   Kim, Jung Hoon ^b   Hur, Kyung Yul ^b   Jin, So Young ^b   Shim, Chan Sup ^a,b  

^a Department of Internal Medicine   (South Korea)

^b Soonchunhyang University College of Medicine   (South Korea)

Author keywords

Gastric Stromal Tumor; Hemoperitoneum; Protein c kit; Proto Oncogene; Rupture; Sfomach Neoplasms

Indexed keywords

CD34 ANTIGEN; STEM CELL FACTOR;

ABDOMINAL MASS; ABDOMINAL PAIN; ABDOMINAL RADIOGRAPHY; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYST; CYST RUPTURE; EMERGENCY SURGERY; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; HEMOPERITONEUM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; MALE; MEDICAL EXAMINATION; PALPATION; PERITONEAL CAVITY;

EID: 9144225397     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2003.18.5.751     Document Type: Article

References (16)

1. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Muhammad Tunio G, Matsuzawa Y, Kanakura Y, Shinomura Y, Kitamura Y. Gain-of-function mutations of c-Kt in human gastrointestinal stromal tumors. Science 1998; 279: 577-80.
2. Miettinen M, Lasota J. Gastrointestinal stromal tumors; definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001; 438: 1-12.
3. Ueyama T, Guo K-J, Hashimoto H, Daimaru Y, Enjoji M. A clinicopathologic and immunohistochemical study of gastrointestinal stromal tumors. Cancer 1992; 69: 947-55.
4. Miettinen M, Sarlomo-Rikala M, Sobin LH, Lasota J. Gastrointestinal stromal tumors and leiomyosarcomas in the colon: a dinicopathologic, immunohistochemical, and molecular genetic study of 44 cases. Am J Surg Pathol 2000; 24: 1339-52.
5. Maeda H, Yamagata A, Nishikawa S, Yoshinaga K, Kobayashi S, Nishi K, Nishikawa S. Requirment of c-kit for development of intestinal pacemaker system. Development 1992; 116: 369-75.
6. Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM. Gastrointestinal pacemaker cell tumor (GIPACT). Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 1998; 152: 1259-69.
7. Pera M, Saenz A, Fernandez-Cruz L. Hemoperitoneum due to a ruptured gastric stromal tumor. Dig Surg 1999; 16: 248-9.
8. Kitabayashi K, Seki T, Kishimoto K, Saitoh H, Ueno K, Kita I, Takashima S, Kurose N, Nojima T. A spontaneously ruptured gastric stromal tumor presenting as generalized peritonitis: report of a case. Surg Today 2001; 31: 350-4.
9. Hasegawa T, Matsuno Y, Shimoda T, Hirohashi S. Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and progrostic classification based on tumor size and MIB-1 grade. Hum pathol 2002; 33: 669-79.
10. Cunningham RE, Federspiel BH, McCarthy WF, Sobin LH, O'Leary TJ. Predicting prognosis of gastrointestinal smooth muscle tumors. Role of clinical and histologic evolution, flow cytometry, and image cytometry. Am J Surg Pathol 1993; 17: 588-94.
11. Rudolph P, Gloeckner K, Parwaresch R, Harms D, Schmidt D. Immunophenotype, proliferation, DNA-ploidy, and biological behavior of gastrointestinal stromal tumors: a multivariate clinicopathologic study. Hum Pathol 1998; 29: 791-800.
12. Lerma E, Oliva E, Tugues D, Prat J. Stromal tumors of the gastrointestinal tract: a clinicopathological and ploidy analysis of 33 cases. Virchows Arch 1994; 424: 19-24.
13. Ando N, Goto H, Niwa Y, Hirooka Y, Ohmiya N, Nagasaka T, Hayakawa T. The diagnosis of GI stromal tumors with EUS-guided fine needle aspiration with immunohistochemical analysis. Gastrointest Endosc 2002; 1: 37-43.
14. Ng EH, Pollock RE, Munsell MF, Atkinson EN, Romsdahl MM. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Ann Surg 1991; 215: 68-77.
15. Joensuu H, Roberts PJ, Sarlomo-Rikala M, Andersson LC, Tervahartiala P, Tuveson D, Silberman S, Capdeville R, Dimitrijevic S, Druker B, Demetri GD. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001; 344: 1052-6.
16. van Oosterom AT, Judson I, Verweij J, Stroobants S, Donato di Paola E, Dimitrijevic S, Martens M, Webb A, Sciot R, Van Glabbeke M, Silberman S, Nielsen OS, European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study. Lancet 2001; 358: 1421-3.